Novo Nordisk A/S ADR buy StockNews.com
Start price
21.12.24
/
50%
€84.00
Target price
21.12.25
-
Performance (%)
-49.11%
Price
01.08.25
€41.65
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Novo Nordisk A/S ADR is performing very badly with a performance of -49.11%. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 21.12.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -31.833% | -31.833% |
| iShares Core DAX® | -3.352% | -0.947% |
| iShares Nasdaq 100 | -0.740% | 3.167% |
| iShares Nikkei 225® | -1.885% | -0.531% |
| iShares S&P 500 | -0.952% | 2.583% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NVO provided by MarketBeat
Stopped prediction by StockNews_com for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€102.50
14.12.24
14.12.24
-
14.12.25
14.12.25
-58.29%
01.08.25
01.08.25
